Telescope Therapeutics

Telescope Therapeutics is developing first-in-class therapies for cardiac fibrosis, a key driver of heart failure. By targeting the urotensin receptor with human-relevant stem cell-based models, we aim to deliver the first therapy that reshapes post-heart attack healing.